A British mum-of-two died suddenly at the age of 34 recently after allegedly falling violently ill following the consumption ...

An experimental therapy undergoing preclinical studies, HS-10535 targets GLP-1 receptors similar to Novo and Lilly’s ...

Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

Nestle is launching protein shots in the United States which it says help suppress appetite for people looking to shed pounds ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

( MENAFN - Baystreet) Merck (NYSE:MRK) on Wednesday said it has snagged the rights to an experimental weight loss pill from ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and ...

News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...

Merck & Co. has secured a licensing agreement with Chinese drugmaker Hansoh Pharma for an experimental oral weight-loss drug, ...

The WHO comments on new weight-loss drugs by Novo Nordisk and Eli Lilly, emphasizing their potential to combat obesity alongside other health strategies. While promising, WHO stresses that these ...